Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Imine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111057729A details a green enzymatic route for Larotretinib intermediates, offering high ee values and cost reduction in API manufacturing.
Patent CN118374465B reveals enzymatic route for (S)-nicotine. Achieves 99.1% ee value. Offers scalable biocatalysis for reliable pharmaceutical intermediates supplier chains.
Novel enzyme process for chiral amine intermediate. High purity, mild conditions, scalable for pharma manufacturing.
Patent CN112795603B reveals a high-efficiency IRED method for chiral pyrrolidines, offering superior purity and green manufacturing advantages.
Advanced synthesis of 2-imine-1,10-phenanthroline ligands via non-toxic lithiation. Enhances supply chain safety and reduces costs in polyolefin manufacturing.
Patent CN121471044A reveals cobalt catalysis for sulfoximine guanidine. Enables mild conditions and high efficiency for reliable pharmaceutical intermediate supply chains.
Patent CN103772348B reveals water-based copper catalysis for high-purity agrochemical intermediates with reduced environmental impact and scalable production capabilities.
Novel water-based synthesis offers high yield and eco-friendly production for reliable agrochemical intermediate supplier partnerships globally.
Patent CN118978656B reveals stable porous organic cages for iodine adsorption. Discover cost reduction in environmental chemical manufacturing and supply chain advantages.
Patent CN116410108B details a novel cyclic 1,3-diketone diimine synthesis enabling efficient alcohol removal. This breakthrough offers significant supply chain and cost advantages for chemical manufacturing.
Patent CN101314581B details a gold-catalyzed synthesis of N-sulfonyl ketimines offering mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Novel electrophilic thioarylation reagent synthesis via mild conditions. High stability reagent for pharmaceutical intermediates manufacturing cost reduction.
Patent CN1390198A reveals a novel ketimine preparation method eliminating TiCl4. Achieve high-purity sertraline intermediates with reduced ecological impact and cost.
Patent CN114591348A reveals a mild Cs2CO3-catalyzed route for benzothienopyrrole synthesis. Discover cost-effective manufacturing and high-yield scalability for pharma intermediates.
Patent CN103333101B reveals a novel Cu-catalyzed synthesis for pyridyl sulfoximine intermediates. Discover cost-effective, scalable solutions for insecticide manufacturing supply chains.
Deep dive into enantioselective sulfoximine synthesis via iron-catalyzed oxidation. Offers cost reduction in agrochemical intermediate manufacturing and scalable supply solutions.
Novel synthesis of cyclic 1,3-diketodiimines for high-purity solvent purification. Cost-effective, scalable process for removing trace alcohols in pharma.
Patent CN114989058B reveals a metal-free catalytic route for high-purity chiral chlorosulfoximines, offering significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN118164963A reveals a novel imine reduction route for Lynacarv. Achieves >99% ee value with reduced cost and enhanced supply chain reliability for global buyers.
Patent CN117165966B reveals metal-free electrochemical method. Offers significant cost reduction and supply chain reliability for high-purity pharma intermediates manufacturing.